Thursday

27th Jul 2017

Merck stops cancer drug supply to Greek hospitals

  • The pharmaceutical industry says it has contributed billions to crisis-hit EU countries (Photo: www.freeimages.co.uk)

German drug company Merck has halted life-saving cancer drug shipments to Greek public hospitals.

Its chief financial officer, Matthias Zachert told German paper Boersen-Zeitung on Saturday (3 November) that the crisis-struck country has not paid its bills.

Thank you for reading EUobserver!

Subscribe now and get 40% off for an annual subscription. Sale ends soon.

  1. €90 per year. Use discount code EUOBS40%
  2. or €15 per month
  3. Cancel anytime

EUobserver is an independent, not-for-profit news organization that publishes daily news reports, analysis, and investigations from Brussels and the EU member states. We are an indispensable news source for anyone who wants to know what is going on in the EU.

We are mainly funded by advertising and subscription revenues. As advertising revenues are falling fast, we depend on subscription revenues to support our journalism.

For group, corporate or student subscriptions, please contact us. See also our full Terms of Use.

If you already have an account click here to login.

"It only affects Greece, where we have been faced with many problems. It's just the one product," he said.

Reuters reports that the cancer-fighting drug is called Erbitux. While the medication will no longer be available at public hospitals, Greeks can still purchase it directly from pharmacies.

The drug fights colorectal cancer and head and neck cancer and is Merck's second best-selling product. In 2011, it generated some €855 million in profits.

The Merck Group reported total revenue €2.8 billion in the second quarter of 2012, an 11.6 percent increase on quarter two last year.

An report in August by GlobalData, a market intelligence analysis group, said that pharmacies in Greece have dropped prices so that cash-strapped citizens can pay for them.

It added that the cheaper drugs have created a "lucrative export carry trade" for Greeks re-selling them over the border.

For its part, the European Federation of Pharmaceutical Industries (Efpia), a Brussels-based trade body, on Sunday sent a letter to the Greek government with a plan to maintain drug supplies in light of its near-empty state coffers.

Efpia's text - seen by Reuters - says international drug companies would be willing to ship supplies to Greece if the government caps outpatient pharmaceutical expenditure at €2.9 billion in 2012.

The news agency says Efpia wants the Greek government to pay off its overdue bills and maintain a balanced sheet.

"Setting a growth cap or budget ceiling is not something we have ever liked to do in the past, but in the current environment it is better to do that and have some stability," Richard Bergstrom, Efpia's director general, told Reuters.

Efpia says Europe's pharmaceutical industry has contributed some €7 billion in the form of rebates and discounts between 2010 and 2011 to Greece, Ireland, Italy, Portugal and Spain.

The figure represents around 8 percent of the industry's annual turnover in those markets.

Focus

Power to the patient

Doctors, it is said, are not what can be called early adopters of new technologies. Any healthcare revolution, then, will have to come through patients. Or rather, consumers, because patients of the 21st century make their own decisions.

Parents of EU children win right to stay

Countries cannot automatically refuse residence to parents of EU children simply because the other parent could care for the minor, the EU's top court ruled on Wednesday.

News in Brief

  1. Werner Hoyer re-appointed as EU investment bank chief
  2. Spanish PM denies knowledge of party corruption
  3. France 'routinely' abuses migrants, says NGO
  4. Swedish government rocked by data scandal
  5. Member states relocate 3,000 migrants in June
  6. Top EU jurist says Malta's finch-trapping against EU law
  7. EU judges rule to keep Hamas funds frozen
  8. EU court rejects passenger data deal with Canada

Stakeholders' Highlights

  1. UNICEFReport: Children on the Move From Africa Do Not First Aim to Go to Europe
  2. Counter BalanceOut for Summer, Ep. 2: EIB Promoting Development in Egypt - At What Cost?
  3. EU2017EELocal Leaders Push for Local and Regional Targets to Address Climate Change
  4. European Healthy Lifestyle AllianceMore Women Than Men Have Died From Heart Disease in Past 30 Years
  5. European Jewish CongressJean-Marie Le Pen Faces Trial for Oven Comments About Jewish Singer
  6. ACCAAnnounces Belt & Road Research at Shanghai Conference
  7. ECPAFood waste in the field can double without crop protection. #WithOrWithout #pesticides
  8. EU2017EEEstonia Allocates €1 Million to Alleviate Migratory Pressure From Libya in Italy
  9. Dialogue PlatformFethullah Gulen's Message on the Anniversary of the Coup Attempt in Turkey
  10. Martens CentreWeeding out Fake News: An Approach to Social Media Regulation
  11. European Jewish CongressEJC Concerned by Normalisation of Antisemitic Tropes in Hungary
  12. Counter BalanceOut for Summer Ep. 1: How the EIB Sweeps a Development Fiasco Under the Rug

Latest News

  1. Corbyn re-opens Labour's single market wound
  2. Visegrad lobby makes food quality an EU issue
  3. EU court could dismiss national borders in cyberspace
  4. Confusion swirls around Macron's Libya 'hotspots'
  5. Insults fly after EU ultimatum to Poland
  6. UK requests EU migration study, 13 months after Brexit vote
  7. EU defends airline data-sharing after court ruling
  8. Stop blaming Trump for Poland’s democratic crisis